|
[1]尹姗姗, 王宝恩, 王泰龄, 等.复方861治疗慢性乙型肝炎肝纤维化与早期肝硬化的临床研究[J].中华肝脏病杂志, 2004, 12 (8) ∶467-470.
|
|
[2]Pol S, Carnot F, Nalpas B, et al.Reversibility of hepatitis C virus-related cirrhosis[J].Hum Pathol, 2004, 35∶107-112.
|
|
[3]Tarcin O, Avsar K, Demirturk L, et al.In vivo inefficiency of pen-toxifylline and interon-alpha on hepatic fibrosis in biliary-obstruc-ted rats:assessment by tissue collagen content and prolidase activity[J].J Gastroenterol Hepatol, 2003, 18∶437-44.
|
|
[4]Li D, Friedman SL.Liver fibrogenesis and the role of hepatic stellatecells:new insights and prospects for therapy[J].J GastroenterolHepatol, 1999, 14∶618-33.
|
|
[5]Samalaska CP, Winfield EA.Pentoxifylline[J].J Am Acad Derma-tol, 1994, 30∶603-21.
|
|
[6]Berman B, Duncan MR.Pentoxifylline inhibits normal human dermalfibroblast in vitro proliferation, collagen, glycosaminoglycan, and fi-bronectin production, and increases collagenase activity[J].J InvestDermatol, 1989, 92∶605-610.
|
|
[7]Preaux AM, Mallat A, Rosenbaum J, et al.Pentoxifyline inbibitsgrowth and collagen synthesis of cultured human hepatic myofibroblast-like cells[J].Hepatology, 1997, 26∶315-322.
|
|
[8]Pinzani M, Defranco R, Caliguri A, et al.Cellular basis for the useof pentoxifylline as a potential antifibrogenic nicagent[J].J hepatol, 1995, 23 (suppl 1) ∶81A.
|
|
[9]Theresa C Peterson.Pentoxifylline prevents fibrosis in an animalmodel and inhibits platelet-derived growth factor-driven prolifera-tion of fibroblasts[J].Hepatology, 1993, 17 (3) ∶486-93.
|
|
[10]Romanelli M, Caligiuri A, Carloni V, et al.Effect of pentoxifyllineon the degradation of procollagentypeⅠproduced by human hepaticstellate cells in response to transforming growth factorβ1[J].Br JPharmacol, 1997, 122∶1047-1054.
|
|
[11]Alexis D, Guoxing X, Andrea MA, et al.Effect of pentoxifylline onearly proliferation and phenotypic modulation of fibrogenic cells intwo rat models of liver fibrosis and on cultured hepatic stellate cells[J].J Hepatol, 1999, 30∶621-31.
|
|
[12]Hernandez E, Correa A, Bucio L, et al.Pentoxyfylline diminishedacetaldehyde-induced collagen production in hepatic stellate cellsby decreasing interleukin-6 expression[J].Pharmacol Res, 2002, 46∶435-43.
|
|
[13]Theresa C P, Marc R P, Harold A, et al.Selective down-regula-tion of c-jun gene expression by pentoxifylline and c-jun antisenseinterrupts platelet-derived growth factor signaling:pentoxifylline in-hibits phosphorylation of c-jun on serine 73[J].Mol Pharmacol, 2002, 61∶1476-88.
|
|
[14]Raetsch C, Jia JD, Boigk G, et al.Pentoxifylline downregulatesprofibrogenic cytokines and procollagenⅠexpression in rat seconda-ry biliary fibrosis[J].Gut, 2002, 50∶241-7.
|
|
[15]Kwan SL, Howard BC, Karl H, et al.Pentoxifylline blocks hepaticstellate cell activation independently of phosphodiesterase inhibitoryactivity[J].Am J Physiol Gastrointes Liver Physiol, 1997, 273∶G1094-G1100.
|
|
[16]伍严安, 高春芳, 万伟东, 等.已酮可可碱对人αl (Ⅰ) 前胶原基因启动子活性的影响[J].中华肝脏病杂志, 2001, 9 (2) ∶70-72.
|
|
[17]熊莉娟, 李淑莉, 罗端德, 等.已酮可可碱对血吸虫病肝纤维化小鼠血清TNF-α、IFN-γ的影响[J].中国寄生虫病防治杂志, 2002, 15 (5) ∶300-301.
|
|
[18]张瑞红, 钱绍诚, 吕洪敏, 等.已酮可可碱抗大鼠肝纤维化的实验研究[J].天津医药, 2002, 30 (4) ∶225-227.
|
|
[19]Wang CY, Mayo MW, Baldwin AS, et al.TNF and cancer therapyinduce apoptosis:potentiation by inhibition of NF Kappa b[J].Sci-ence, 1996, 274∶784-787.
|
|
[20]Liu HL, Li XH, Wang DY, et al.Matrix metalloproteinase-2 andtissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver[J].World J Gastroenterol, 2000, 6∶881-884.
|
|
[21]Pinznj M, Marra F, Gallgiuki A, et al.Inhibition by pentoxifyllineof extracellular signal-regulated kinase activation by platelet-de-rived growth factor in hepatic stellate cells[J].Br J Pharmacol, 1996, 119∶1117.
|
|
[22]Schuppan D, Porov Y.Hepatic fibrosis:from bench to bedside[J].J Gastroenterol Hepatol, 2002, 17 (suppl 3) ∶S 300-305.
|
PDF下载 ( 173 KB)
本文二维码
下载:
